Latest news with #pennystocks
Yahoo
7 days ago
- Business
- Yahoo
Origin Materials And 2 Additional Promising Penny Stocks
The U.S. stock market has been riding a wave of optimism, with the S&P 500 recently hitting new highs amid positive trade deal developments and anticipation of earnings reports from major companies. In such a buoyant market, investors often look beyond the large-cap stocks to explore opportunities in smaller segments like penny stocks. While "penny stocks" might seem like an outdated term, they still represent a vibrant area for investment, offering potential growth at lower price points when backed by strong financials. Top 10 Penny Stocks In The United States Name Share Price Market Cap Financial Health Rating Waterdrop (WDH) $1.67 $614.83M ★★★★★★ CuriosityStream (CURI) $4.60 $258.53M ★★★★★★ WM Technology (MAPS) $0.9931 $161.13M ★★★★★★ Perfect (PERF) $2.51 $266.84M ★★★★★★ Tuniu (TOUR) $0.9326 $101.15M ★★★★★★ Safe Bulkers (SB) $4.14 $416.4M ★★★★☆☆ Cardno (COLD.F) $0.1701 $6.64M ★★★★★★ BAB (BABB) $0.8009 $6.14M ★★★★★★ Lifetime Brands (LCUT) $4.65 $103.33M ★★★★★☆ Tandy Leather Factory (TLF) $3.44 $28.6M ★★★★★★ Click here to see the full list of 415 stocks from our US Penny Stocks screener. Let's explore several standout options from the results in the screener. Origin Materials Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Origin Materials, Inc. operates as a carbon-negative materials company and has a market cap of approximately $89.61 million. Operations: The company generates revenue from its Specialty Chemicals segment, which amounted to $29.89 million. Market Cap: $89.61M Origin Materials, Inc. presents a mixed picture for investors interested in penny stocks. The company has successfully reduced its debt to equity ratio from 44.8% to 1.1% over five years and maintains more cash than total debt, indicating financial prudence. However, it remains unprofitable with a negative return on equity of -30.59%, and earnings have declined significantly over the past five years by 26.6% annually. Despite this, Origin's short-term assets comfortably cover both short- and long-term liabilities, providing some financial stability amidst high share price volatility and an inexperienced board with an average tenure of 2.2 years. Unlock comprehensive insights into our analysis of Origin Materials stock in this financial health report. Learn about Origin Materials' historical performance here. Cassava Sciences Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Cassava Sciences, Inc. is a clinical-stage biotechnology company focused on developing drugs for neurodegenerative diseases, with a market cap of approximately $111.11 million. Operations: Cassava Sciences, Inc. currently does not report any revenue segments. Market Cap: $111.11M Cassava Sciences, Inc. offers a complex profile for penny stock investors. Despite being pre-revenue with no significant income streams, the company is debt-free and has short-term assets of US$120.2 million that exceed both its short- and long-term liabilities, indicating some financial resilience. However, it faces challenges such as increased losses over five years at 27.4% annually and less than a year of cash runway if its free cash flow continues to decrease at historical rates. Recent index reclassifications highlight volatility in investor sentiment as it shifts from growth to value benchmarks amidst ongoing strategic changes. Click here and access our complete financial health analysis report to understand the dynamics of Cassava Sciences. Assess Cassava Sciences' previous results with our detailed historical performance reports. OraSure Technologies Simply Wall St Financial Health Rating: ★★★★★★ Overview: OraSure Technologies, Inc. develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices globally with a market cap of $243.10 million. Operations: The company's revenue primarily comes from its Diagnostics and Molecular Solutions segment, totaling $161.63 million. Market Cap: $243.1M OraSure Technologies, Inc. presents a mixed picture for penny stock investors. The company is unprofitable but has managed to reduce its losses over the past five years by 18.8% annually. Its short-term assets of US$313.8 million comfortably cover both short- and long-term liabilities, suggesting financial stability without any debt burden. Recent developments include the launch of HEMAcollect™ PROTEIN for proteomic research and its addition to the Russell 2000 indices, indicating market recognition despite ongoing challenges with profitability and declining revenues from US$54.13 million to US$29.93 million year-over-year in Q1 2025 results. Click to explore a detailed breakdown of our findings in OraSure Technologies' financial health report. Gain insights into OraSure Technologies' future direction by reviewing our growth report. Next Steps Embark on your investment journey to our 415 US Penny Stocks selection here. Contemplating Other Strategies? We've found 17 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ORGN SAVA and OSUR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
22-07-2025
- Business
- Yahoo
UK Penny Stocks To Watch In July 2025
The UK stock market has recently faced challenges, with the FTSE 100 index dropping due to weak trade data from China, highlighting ongoing global economic concerns. Despite these broader market fluctuations, investors often look beyond established names to explore opportunities in smaller companies. Penny stocks, though an older term, continue to capture interest for their potential growth and affordability. In this article, we explore three penny stocks that stand out for their financial strength and resilience amidst current market conditions. Top 10 Penny Stocks In The United Kingdom Name Share Price Market Cap Financial Health Rating FRP Advisory Group (AIM:FRP) £1.20 £301.38M ★★★★★☆ Foresight Group Holdings (LSE:FSG) £4.57 £508.81M ★★★★★★ Warpaint London (AIM:W7L) £4.15 £347.39M ★★★★★★ Van Elle Holdings (AIM:VANL) £0.396 £42.74M ★★★★★★ System1 Group (AIM:SYS1) £4.25 £53.93M ★★★★★★ LSL Property Services (LSE:LSL) £3.05 £313.01M ★★★★★☆ Begbies Traynor Group (AIM:BEG) £1.255 £198.36M ★★★★★★ Croma Security Solutions Group (AIM:CSSG) £0.82 £11.29M ★★★★★★ Braemar (LSE:BMS) £2.31 £69.82M ★★★★★★ ME Group International (LSE:MEGP) £2.17 £819.53M ★★★★★★ Click here to see the full list of 296 stocks from our UK Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. accesso Technology Group Simply Wall St Financial Health Rating: ★★★★★★ Overview: accesso Technology Group plc, with a market cap of £167.97 million, develops technology solutions for the attractions and leisure industry through its subsidiaries. Operations: The company generates revenue from three main segments: Ticketing ($113.03 million), Guest Experience ($31.46 million), and Professional Services ($7.80 million). Market Cap: £167.97M accesso Technology Group plc, with a market cap of £167.97 million, has shown consistent profitability growth over the past five years, increasing earnings by 62.9% annually. Despite recent guidance indicating lower revenue expectations for 2025, the company maintains strong financial health with short-term assets covering both short and long-term liabilities. The stock trades below its fair value estimate and is considered a good relative value compared to peers. However, the management team is relatively new with an average tenure of 1.3 years, which could present challenges in strategic execution moving forward. Take a closer look at accesso Technology Group's potential here in our financial health report. Understand accesso Technology Group's earnings outlook by examining our growth report. Cake Box Holdings Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Cake Box Holdings Plc operates in the United Kingdom, specializing in the retail of fresh cream celebration cakes, with a market cap of £81.40 million. Operations: The company's revenue is entirely generated from its operations in the United Kingdom, amounting to £0.000001 million. Market Cap: £81.4M Cake Box Holdings Plc, with a market cap of £81.40 million, reported annual sales of £42.78 million and net income of £4.37 million for the year ended March 2025. The company trades at 43% below its estimated fair value and has satisfactory debt levels with interest payments well covered by EBIT. However, its short-term assets do not cover long-term liabilities, and dividend coverage remains weak despite a proposed increase to 10.2 pence per share for the year. While revenue is forecasted to grow annually by 18.1%, recent negative earnings growth poses challenges amidst a relatively inexperienced board. Navigate through the intricacies of Cake Box Holdings with our comprehensive balance sheet health report here. Examine Cake Box Holdings' earnings growth report to understand how analysts expect it to perform. Impax Asset Management Group Simply Wall St Financial Health Rating: ★★★★★★ Overview: Impax Asset Management Group Plc is a publicly owned investment manager with a market cap of approximately £263.66 million. Operations: The company generates revenue primarily from its investment management services, amounting to £160.42 million. Market Cap: £263.66M Impax Asset Management Group, with a market cap of £263.66 million and revenues of £160.42 million, is actively seeking acquisitions to bolster its investment strategy in private equity and fixed income. The company has initiated a share buyback program worth up to £10 million, aiming for capital flexibility and shareholder returns. Despite negative earnings growth over the past year, Impax's management team is seasoned with an average tenure of 14.5 years, and the firm maintains high-quality earnings without debt concerns. However, dividend coverage remains weak at 12.87%, indicating potential sustainability issues despite strong asset liability coverage. Unlock comprehensive insights into our analysis of Impax Asset Management Group stock in this financial health report. Evaluate Impax Asset Management Group's prospects by accessing our earnings growth report. Seize The Opportunity Access the full spectrum of 296 UK Penny Stocks by clicking on this link. Looking For Alternative Opportunities? We've found 17 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:ACSO AIM:CBOX and AIM:IPX. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
17-07-2025
- Business
- Yahoo
3 Promising Penny Stocks With Market Caps Over $40M
The U.S. stock market has been navigating a period of volatility, with major indices such as the Dow Jones Industrial Average and the S&P 500 experiencing fluctuations amid geopolitical tensions and economic policy discussions. Despite these broader market challenges, penny stocks remain an intriguing area for investors, representing smaller or newer companies that can offer potential value when backed by strong financials. In this context, we explore three penny stocks that exhibit financial robustness and growth potential, highlighting their promise in delivering opportunities for investors seeking to uncover hidden gems in the market. Top 10 Penny Stocks In The United States Name Share Price Market Cap Financial Health Rating Waterdrop (WDH) $1.43 $528.03M ★★★★★★ CuriosityStream (CURI) $4.38 $253.92M ★★★★★★ WM Technology (MAPS) $0.9129 $162.49M ★★★★★★ Perfect (PERF) $2.36 $232.21M ★★★★★★ Tuniu (TOUR) $0.9326 $100.94M ★★★★★★ Safe Bulkers (SB) $4.01 $417.42M ★★★★☆☆ Cardno (COLD.F) $0.1701 $6.64M ★★★★★★ BAB (BABB) $0.81645 $6.03M ★★★★★☆ Lifetime Brands (LCUT) $4.58 $104.9M ★★★★★☆ North European Oil Royalty Trust (NRT) $4.84 $44.39M ★★★★★★ Click here to see the full list of 426 stocks from our US Penny Stocks screener. Let's dive into some prime choices out of the screener. Burning Rock Biotech Simply Wall St Financial Health Rating: ★★★★★★ Overview: Burning Rock Biotech Limited focuses on developing and selling cancer therapy selection tests in China, with a market cap of $49.85 million. Operations: Burning Rock Biotech generates revenue through its In-Hospital Channel (CN¥224.79 million), Central Laboratory Channel (CN¥166.33 million), and Pharma Research and Development Channel (CN¥132.16 million). Market Cap: $49.85M Burning Rock Biotech, with a market cap of US$49.85 million, reported first-quarter sales of CN¥133.08 million, up from CN¥125.62 million a year earlier, while reducing its net loss significantly to CN¥13.5 million from CN¥121.55 million. Despite being unprofitable, it has shown progress in reducing losses over five years and benefits from an experienced management team with an average tenure of 9.3 years. The company is debt-free and possesses sufficient cash runway for over three years based on current free cash flow levels, although its share price remains highly volatile compared to other U.S.-listed stocks. Dive into the specifics of Burning Rock Biotech here with our thorough balance sheet health report. Gain insights into Burning Rock Biotech's historical outcomes by reviewing our past performance report. loanDepot Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: loanDepot, Inc. operates in the United States by originating, financing, selling, and servicing residential mortgage loans with a market cap of approximately $501.46 million. Operations: The company generates revenue primarily from the originating, financing, and selling of mortgage loans, amounting to $1.09 billion. Market Cap: $501.46M loanDepot, Inc., with a market cap of US$501.46 million, recently joined multiple Russell indexes, potentially increasing its visibility among investors. Despite a high net debt to equity ratio and ongoing unprofitability with a negative return on equity, the company has not diluted shareholders significantly over the past year. Its short-term assets of US$4.5 billion cover both short- and long-term liabilities, providing some financial stability amidst challenges. Earnings are forecasted to grow substantially at 112.47% annually, yet its current losses have increased by 43.4% per year over five years, reflecting ongoing financial hurdles despite good relative value compared to peers. Take a closer look at loanDepot's potential here in our financial health report. Learn about loanDepot's future growth trajectory here. NameSilo Technologies Simply Wall St Financial Health Rating: ★★★★★☆ Overview: NameSilo Technologies Corp. operates through its subsidiaries to offer domain name registration services across the United States, various regions in Asia, Australasia, and internationally, with a market cap of $77.37 million. Operations: The company generates revenue primarily from Domain Registration and Related Services, amounting to CA$58.30 million. Market Cap: $77.37M NameSilo Technologies, with a market cap of CA$77.37 million, has shown revenue growth, reporting CA$15.87 million for Q1 2025 compared to CA$12.8 million a year prior. Despite this, the company faces financial challenges as its short-term assets of CA$32.6 million do not cover liabilities of CA$45.9 million, and it remains unprofitable with negative return on equity at 38.43%. However, it has reduced its debt-to-equity ratio significantly over five years and holds more cash than total debt, offering some financial resilience despite auditor concerns about its ability to continue as a going concern. Get an in-depth perspective on NameSilo Technologies' performance by reading our balance sheet health report here. Review our historical performance report to gain insights into NameSilo Technologies' track record. Turning Ideas Into Actions Navigate through the entire inventory of 426 US Penny Stocks here. Ready For A Different Approach? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BNR LDI and URLO.F. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
14-07-2025
- Business
- Yahoo
Stifel Affirms ‘Buy' rating on Eos Energy Enterprises (EOSE) Amid Capital injection
Eos Energy Enterprises, Inc. (NASDAQ:EOSE) is one of the best green energy penny stocks to buy right now. On July 2, Stifel reiterated a 'Buy' rating on the stock and an 8.50 price target. The bullish stance comes as the stock shows impressive momentum following a receipt of additional government funding. A technician wearing a safety vest standing alongside a commercial-scale energy storage stack. The company has secured $22.7 million in funding as part of the U.S. Department of Energy's (DOE) Loan Programs Office. It marks the second time Eos Energy Enterprises has secured financing under the facility. It has already utilized $90.8 million under the initial tranche of a $303.5 million loan facility. Eos Energy is to use the new funding to support capacity expansion efforts as it seeks to meet the growing demand for its solutions. The company is in the process of scaling its manufacturing capabilities. It has also made significant progress in strengthening its balance sheet. Eos Energy Enterprises, Inc. (NASDAQ:EOSE) specializes in the designing, manufacturing, and marketing of zinc-based energy storage solutions for utility-scale, microgrid, and commercial and industrial applications. It provides long-duration energy storage systems, primarily using its Znyth zinc battery technology. While we acknowledge the potential of EOSE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Most Popular AI Penny Stocks to Buy According to Billionaires and 10 Best Defensive Stocks to Buy in a Volatile Market. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10-07-2025
- Business
- Yahoo
Discover 3 European Penny Stocks With Market Caps Under €90M
As the European markets navigate a landscape of mixed returns and steady inflation, investors are exploring diverse opportunities beyond traditional blue-chip stocks. Penny stocks, though an older term, continue to represent intriguing prospects for those interested in smaller or newer companies. With solid financial foundations and potential for growth at lower price points, these stocks offer a unique opportunity to uncover hidden value within the market. Name Share Price Market Cap Financial Health Rating Maps (BIT:MAPS) €3.44 €45.69M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.60 SEK269.95M ★★★★★★ IAMBA Arad (BVB:FERO) RON0.51 RON17.25M ★★★★★★ Cellularline (BIT:CELL) €2.83 €59.69M ★★★★★☆ Fondia Oyj (HLSE:FONDIA) €4.72 €17.65M ★★★★★★ Abak (WSE:ABK) PLN4.20 PLN11.32M ★★★★★★ Bredband2 i Skandinavien (OM:BRE2) SEK2.455 SEK2.35B ★★★★☆☆ Hifab Group (OM:HIFA B) SEK3.64 SEK221.45M ★★★★★★ Deceuninck (ENXTBR:DECB) €2.115 €292.01M ★★★★★★ Netgem (ENXTPA:ALNTG) €0.978 €32.98M ★★★★★★ Click here to see the full list of 326 stocks from our European Penny Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Ilkka Oyj, with a market cap of €88.10 million, operates in the publishing and printing sectors both in Finland and internationally through its subsidiaries. Operations: The company generates revenue primarily from its Marketing and Technology Services segment, which accounted for €32.64 million. Market Cap: €88.1M Ilkka Oyj, with a market cap of €88.10 million, has shown mixed financial performance recently. The company reported a net loss of €0.992 million in Q1 2025 despite an increase in sales to €9.42 million from the previous year. While its short-term assets exceed both short and long-term liabilities, indicating strong liquidity management, profit margins have decreased from last year and earnings growth has been negative over the past year. Although debt is well-covered by operating cash flow and there's no recent shareholder dilution, the dividend is not well-supported by earnings or cash flows, highlighting potential sustainability concerns. Unlock comprehensive insights into our analysis of Ilkka Oyj stock in this financial health report. Assess Ilkka Oyj's future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Orthex Oyj is a houseware company that designs, produces, markets, and sells household products across the Nordics, Europe, and internationally with a market cap of €82.93 million. Operations: The company's revenue is primarily derived from its Housewares & Accessories segment, amounting to €88.70 million. Market Cap: €82.93M Orthex Oyj, with a market cap of €82.93 million, trades at 43.5% below its estimated fair value and has not seen significant shareholder dilution over the past year. Its short-term assets exceed both short and long-term liabilities, demonstrating solid liquidity management. The company's debt is well-covered by operating cash flow and interest payments are adequately covered by EBIT. Despite a decline in earnings growth over the past year, Orthex maintains high-quality earnings and offers dividends of €0.22 per share for 2024 paid in two instalments. However, net profit margins have decreased from last year's figures. Click here to discover the nuances of Orthex Oyj with our detailed analytical financial health report. Explore Orthex Oyj's analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Sevenet S.A. is an IT company that offers ICT solutions to enterprises and institutions mainly in Poland, with a market cap of PLN28.26 million. Operations: The company generates revenue from its Computer Networks segment, totaling PLN148.48 million. Market Cap: PLN28.26M Sevenet S.A., with a market cap of PLN28.26 million, shows mixed financial health typical of penny stocks. The company's revenue from its Computer Networks segment reached PLN148.48 million, indicating it is not pre-revenue. Despite a significant reduction in debt over the past five years and having more cash than debt, Sevenet's earnings have declined by 19.2% annually over the same period, with recent profit margins dropping to 0.9%. While short-term assets cover short-term liabilities adequately, long-term liabilities remain uncovered by current assets, and dividends are not well-supported by free cash flow. Get an in-depth perspective on Sevenet's performance by reading our balance sheet health report here. Gain insights into Sevenet's historical outcomes by reviewing our past performance report. Dive into all 326 of the European Penny Stocks we have identified here. Interested In Other Possibilities? We've found 16 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include HLSE:ILKKA2 HLSE:ORTHEX and WSE:SEV. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
